The purpose of this study is to determine the safety and efficacy of nab-paclitaxel and gemcitabine with or without olaratumab in the treatment of first-line metastatic pancreatic cancer.
Principal Investigator
Ravindranath Duggirala
Roy Resendez
roy.resendez@tamusa.edu